Mariaelena Capone Selected Research

Brain Neoplasms (Brain Tumor)

12/2020

Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mariaelena Capone Research Topics

Disease

46	Melanoma (Melanoma, Malignant) 05/2024 - 02/2009
17	Neoplasms (Cancer) 01/2024 - 03/2013
3	Neoplasm Metastasis (Metastasis) 01/2023 - 08/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023
1	Cytokine Release Syndrome 03/2023
1	COVID-19 03/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023
1	Disease Progression 01/2022
1	Vitiligo 01/2022
1	Brain Neoplasms (Brain Tumor) 12/2020
1	Circulating Neoplastic Cells 09/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2009

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2016
12	IpilimumabIBA 01/2023 - 03/2013
9	NivolumabIBA 11/2023 - 12/2017
9	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2017
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2023 - 01/2015
4	MicroRNAs (MicroRNA)IBA 03/2024 - 02/2021
4	Adenosine (Adenocard)FDA LinkGeneric 01/2022 - 01/2019
3	dabrafenibIBA 05/2024 - 02/2021
3	CytokinesIBA 03/2023 - 01/2017
3	VemurafenibIBA 01/2023 - 01/2015
3	pembrolizumabIBA 01/2022 - 01/2018
2	trametinibIBA 05/2024 - 11/2023
2	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 08/2013
2	cobimetinibIBA 01/2023 - 01/2021
2	Monoclonal AntibodiesIBA 01/2022 - 09/2019
2	AntibodiesIBA 12/2020 - 03/2013
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 02/2015
1	NestinIBA 11/2023
1	Conditioned Culture MediaIBA 10/2023
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 10/2023
1	Peroxidase (Myeloperoxidase)IBA 10/2023
1	Protons (Proton)IBA 03/2023
1	cemiplimabIBA 01/2023
1	atezolizumabIBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	cyclopropapyrroloindoleIBA 01/2022
1	Interleukin-13IBA 01/2022
1	InterferonsIBA 01/2021
1	CTLA-4 AntigenIBA 12/2020
1	Programmed Cell Death 1 ReceptorIBA 12/2020
1	Adenosine Monophosphate (AMP)IBA 12/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2020
1	Complement System Proteins (Complement)IBA 09/2019
1	NeuregulinsIBA 09/2019
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2019
1	LigandsIBA 01/2019
1	Galectins (Galectin)IBA 01/2019
1	VaccinesIBA 01/2018
1	Blood Proteins (Serum Proteins)IBA 01/2018
1	EnzymesIBA 12/2017
1	Interleukin-15 (Interleukin 15)IBA 01/2017
1	Bleomycin (Blenoxane)FDA LinkGeneric 06/2015
1	MLN8054IBA 02/2015
1	Aurora Kinase AIBA 02/2015
1	InterleukinsIBA 08/2010
1	Interleukin-10 (Interleukin 10)IBA 08/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 08/2010
1	AutoantibodiesIBA 08/2010
1	Interferon-alpha (Interferon Alfa)IBA 08/2010
1	Peptides (Polypeptides)IBA 02/2009
1	NF-kappa B (NF-kB)IBA 02/2009
1	PPAR gammaIBA 01/2009

Therapy/Procedure

27	Therapeutics 05/2024 - 02/2009
12	Immunotherapy 03/2024 - 01/2018
1	Critical Care (Surgical Intensive Care) 03/2023
1	Neoadjuvant Therapy 01/2023
1	Salvage Therapy 11/2022